{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:20Z","timestamp":1792723100370,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01061","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:20:07Z","timestamp":1789143607000},"page":"e01061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors"],"prefix":"10.1016","volume":"23","author":[{"given":"Mirna","family":"Hennawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Kiat","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Lim-Fat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01061_bib1","series-title":"The transition from adolescence to young adulthood","article-title":"Childhood cancer and functional impacts across the care continuum","year":"2020"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/nop\/npab001","article-title":"Adolescent and young adult neuro-oncology: a comprehensive review","volume":"8","author":"Yeo","year":"2021","journal-title":"Neuro-Oncol Pract"},{"issue":"Supplement_4","key":"10.1016\/j.neurot.2026.e01061_bib3","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2018-2022","volume":"27","author":"Price","year":"2025","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JOP.18.00767","article-title":"CNS tumors in adolescents and young adults: the need for a holistic specialized approach","volume":"16","author":"Papageorgiou","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib5","first-page":"242","article-title":"Young adult oncology: the patients and their survival challenges","volume":"57","author":"Bleyer","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neurot.2026.e01061_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2013.00075","article-title":"Unmet support service needs and health-related quality of life among adolescents and young adults with cancer: the AYA HOPE study","volume":"3","author":"Smith","year":"2013","journal-title":"Front Oncol"},{"issue":"19","key":"10.1016\/j.neurot.2026.e01061_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194847","article-title":"Adolescent and young adult (AYA) cancer survivorship practices: an overview","volume":"13","author":"Janssen","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10412","key":"10.1016\/j.neurot.2026.e01061_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11060-020-03437-4","article-title":"Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-kids study","volume":"147","author":"Zumel-Marne","year":"2020","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpn.2025.11.003","article-title":"Seizures in children and adolescents with high-grade glioma: a retrospective, monocentric analysis","volume":"60","author":"Stritzelberger","year":"2025","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-019-02078-w","article-title":"Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course","volume":"139","author":"Wefers","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib12","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00381-017-3572-1","article-title":"Presentation and symptom interval in children with central nervous system tumors. A single-center experience","volume":"33","author":"Stocco","year":"2017","journal-title":"Childs Nerv Syst"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14656566.2020.1751124","article-title":"Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)","volume":"21","author":"Ebrahimi-Fakhari","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.neurot.2026.e01061_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jocn.2020.09.019","article-title":"Intracranial chordoid glioma: a clinical, radiological and pathological study of 14 cases","volume":"80","author":"Zhang","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib15","doi-asserted-by":"crossref","first-page":"dju166","DOI":"10.1093\/jnci\/dju166","article-title":"Impact of treatment site in adolescents and young adults with central nervous system tumors","volume":"106","author":"Wolfson","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00006123-200010000-00018","article-title":"Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors","volume":"47","author":"Albright","year":"2000","journal-title":"Neurosurgery"},{"issue":"Supplement_6","key":"10.1016\/j.neurot.2026.e01061_bib17","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/neuonc\/noac208","article-title":"Laser hyperthermia: Past, present, and future","volume":"24","author":"Schupper","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01061_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/pbc.24958","article-title":"Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the surveillance epidemiology and end results (SEER) database","volume":"61","author":"Bandopadhayay","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib19","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S1470-2045(25)00534-0","article-title":"A prognostic classification system for extent of resection in IDH-Mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group","volume":"26","author":"Karschnia","year":"2025","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-053127","article-title":"Long-term Follow-up care for childhood, adolescent, and young adult cancer survivors","volume":"148","author":"Hudson","year":"2021","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2023.16875","article-title":"Clinical care for people who survive childhood cancer: a review","volume":"330","author":"Bhatia","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/neuonc\/noae259","article-title":"The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma","volume":"27","author":"de la Fuente","year":"2025","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01061_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-Mutant low-grade glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/neuonc\/noae186","article-title":"Central nervous system tumors in adolescents and young adults: a society for neuro-oncology consensus review on diagnosis, management, and future directions","volume":"27","author":"Lim-Fat","year":"2025","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/children9040447","article-title":"Long-term Follow-Up of pediatric CNS tumor Survivors-A selection of relevant long-term issues","volume":"9","author":"Otth","year":"2022","journal-title":"Children"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.6004\/jnccn.2023.0040","article-title":"Adolescent and young adult (AYA) oncology, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"21","author":"Bhatia","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.neurot.2026.e01061_bib27","series-title":"Central nervous system tumours: WHO classification of tumours","year":"2021"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cncr.32675","article-title":"Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: identifying opportunities for intervention","volume":"126","author":"Siembida","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100096","article-title":"Adolescents and young adults (AYA) with cancer: a position paper from the AYA working group of the european society for medical oncology (ESMO) and the european society for paediatric oncology (SIOPE)","volume":"6","author":"Ferrari","year":"2021","journal-title":"ESMO Open"},{"issue":"Suppl 3","key":"10.1016\/j.neurot.2026.e01061_bib30","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1542\/peds.2014-0122F","article-title":"Improving enrollment in clinical trials for adolescents with cancer","volume":"133","author":"Shaw","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.neurot.2026.e01061_bib31","article-title":"Virtual CNS tumor board rounds within the Canadian adolescent and young adult neuro-oncology network","volume":"9","author":"Dave","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"12 Suppl 2","key":"10.1016\/j.neurot.2026.e01061_bib32","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01061_bib33","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","article-title":"World health organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review","volume":"8","author":"Berger","year":"2022","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib34","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/neuonc\/noae142","article-title":"A comparative analysis of IDH-Mutant glioma in pediatric, young adult, and older adult patients","volume":"26","author":"Lim-Fat","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11060-025-05246-z","article-title":"High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscape","volume":"176","author":"Roux","year":"2025","journal-title":"J Neuro Oncol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-025-00962-x","article-title":"A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis","volume":"6","author":"Bennett","year":"2025","journal-title":"Nat Cancer"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib37","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/neuonc\/noaa024","article-title":"High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts","volume":"22","author":"Roux","year":"2020","journal-title":"Neuro Oncol"},{"issue":"20","key":"10.1016\/j.neurot.2026.e01061_bib38","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMra2116344","article-title":"Brain tumors in children","volume":"386","author":"Cohen","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib39","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230777","article-title":"Brain tumor imaging in adolescents and young adults: 2021 WHO updates for molecular-based tumor types","volume":"310","author":"Wagner","year":"2024","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00401-017-1710-1","article-title":"H3-\/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers","volume":"134","author":"Korshunov","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib41","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00401-019-02081-1","article-title":"A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration","volume":"138","author":"Chiang","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.32074\/1591-951X-828","article-title":"Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome","volume":"114","author":"Fabbri","year":"2022","journal-title":"Pathologica"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib43","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3174\/ajnr.A8894","article-title":"Pediatric-type diffuse low-grade gliomas with","volume":"46","author":"Coppola","year":"2025","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.17712\/nsj.2020.5.20200026","article-title":"Angiocentric glioma of brainstem","volume":"25","author":"Almubarak","year":"2020","journal-title":"Neurosciences"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-016-1639-9","article-title":"Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway","volume":"133","author":"Huse","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib47","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/S1470-2045(14)71206-9","article-title":"Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies","volume":"16","author":"Northcott","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib48","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S1470-2045(12)70577-6","article-title":"Molecular diagnostics in paediatric glial tumours","volume":"14","author":"Kim","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib49","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00401-015-1410-7","article-title":"Pilocytic astrocytoma: pathology, molecular mechanisms and markers","volume":"129","author":"Collins","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2026.e01061_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2018.05.003","article-title":"Grade II pleomorphic xanthoastrocytoma; a meta-analysis of data from previously reported 167 cases","volume":"54","author":"Mallick","year":"2018","journal-title":"J Clin Neurosci"},{"issue":"19","key":"10.1016\/j.neurot.2026.e01061_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193406","article-title":"Subependymal giant cell astrocytoma: the molecular landscape and treatment advances","volume":"16","author":"Pucko","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib52","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bpa.12565","article-title":"Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement","volume":"28","author":"Hirose","year":"2018","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-025-01987-0","article-title":"High-grade astrocytoma with piloid features: a single-institution case series and literature review","volume":"13","author":"Goethe","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoncol.2024.5506","article-title":"Molecular testing for the world health organization classification of central nervous system tumors: a review","volume":"11","author":"Horbinski","year":"2025","journal-title":"JAMA Oncol"},{"issue":"35","key":"10.1016\/j.neurot.2026.e01061_bib55","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1200\/JCO.2018.78.9990","article-title":"BRAF inhibition in BRAFV600-mutant gliomas: results from the VE-BASKET study","volume":"36","author":"Kaley","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib56","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0043-1776775","article-title":"Brain tumors in adolescents and young adults: a review","volume":"43","author":"Rousseau","year":"2023","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11060-025-05326-0","article-title":"Expanding morphological spectrum of pilocytic astrocytomas: insights from integrated histopathological and multiomic profiling","volume":"176","author":"Shahin","year":"2025","journal-title":"J Neuro Oncol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib58","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","article-title":"Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations","volume":"389","author":"Bouffet","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib59","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41591-023-02321-8","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nat Med"},{"issue":"7287","key":"10.1016\/j.neurot.2026.e01061_bib60","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-023-02668-y","article-title":"The type II RAF inhibitor tovorafenib in relapsed\/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial","volume":"30","author":"Kilburn","year":"2024","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/13543784.2025.2599455","article-title":"Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?","volume":"34","author":"Petrini","year":"2025","journal-title":"Expert Opin Invest Drugs"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01061_bib63","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.47391\/JPMA.20428","article-title":"Vorasidenib- A paradigm shift in IDH1- or IDH2-Mutant low-grade glioma treatment","volume":"74","author":"Malik","year":"2024","journal-title":"J Pakistan Med Assoc"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib64","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S1470-2045(25)00472-3","article-title":"Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blnd, placebo-controlled, phase 3 trial","volume":"26","author":"Cloughesy","year":"2025","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.neurot.2026.e01061_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162630","article-title":"Targeting of mutant isocitrate dehydrogenase in glioma: a systematic review","volume":"17","author":"Lanman","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"Supplement_2","key":"10.1016\/j.neurot.2026.e01061_bib66","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/neuonc\/noae031","article-title":"ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma","volume":"26","author":"Arrillaga-Romany","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115165","article-title":"Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: results of an international academia-driven compassionate use program","volume":"216","author":"Di Carlo","year":"2025","journal-title":"Eur J Cancer"},{"issue":"12 Suppl 2","key":"10.1016\/j.neurot.2026.e01061_bib68","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00401-023-02668-9","article-title":"Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation","volume":"147","author":"Neyazi","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3171\/2008.9.JNS08117","article-title":"Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study","volume":"110","author":"McGuire","year":"2009","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib71","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01061_bib72","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/neuonc\/noad055","article-title":"Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within international clinical trials: a BIOMECA study","volume":"25","author":"Chapman","year":"2023","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib73","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cncr.31995","article-title":"Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: cure at a cost","volume":"125","author":"Zapotocky","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00401-023-02674-x","article-title":"Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas","volume":"147","author":"Pohl","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2026.e01061_bib75","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.wneu.2017.11.165","article-title":"Adult spinal ependymomas: an epidemiologic study","volume":"111","author":"Khalid","year":"2018","journal-title":"World Neurosurg"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib76","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3171\/2017.9.SPINE17494","article-title":"Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival","volume":"28","author":"Wostrack","year":"2018","journal-title":"J Neurosurg Spine"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib77","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00381-012-1908-4","article-title":"Spinal cord ependymomas in children and adolescents","volume":"28","author":"Benesch","year":"2012","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib78","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00401-019-02056-2","article-title":"MYCN amplification drives an aggressive form of spinal ependymoma","volume":"138","author":"Ghasemi","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00401-018-1888-x","article-title":"Heterogeneity within the PF-EPN-B ependymoma subgroup","volume":"136","author":"Cavalli","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib80","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/neuonc\/nox166","article-title":"EANO guidelines for the diagnosis and treatment of ependymal tumors","volume":"20","author":"Rud\u00e0","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib81","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1227\/neu.0000000000002923","article-title":"Impact of molecular subgroups on prognosis and survival outcomes in posterior fossa ependymomas: a retrospective study of 412 cases","volume":"95","author":"Wang","year":"2024","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib82","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3171\/2021.12.JNS211643","article-title":"Clinical features and surgical outcomes of intracranial and spinal cord subependymomas","volume":"137","author":"Rincon-Torroella","year":"2022","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib83","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S1470-2045(19)30669-2","article-title":"EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma","volume":"20","author":"Franceschi","year":"2019","journal-title":"Lancet Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.neurot.2026.e01061_bib84","article-title":"MDB-49. Outcomes of sonic hedgehog (SHH) medulloblastoma (MB) in children and adults treated with risk-adapted therapy on a prospective international protocol (SJMB12)","volume":"26","author":"Gajjar","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib85","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae064.540","article-title":"MDB-92. Effect of reduced-dose craniospinal irradiation and reduced-dose adjuvant chemotherapy on children and adolescents with WNT medulloblastoma without residual or metastatic disease: results from the SJMB12 clinical trial","volume":"26","author":"Robinson","year":"2024","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib86","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00401-021-02358-4","article-title":"Subgroup and subtype-specific outcomes in adult medulloblastoma","volume":"142","author":"Coltin","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib87","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1093\/neuonc\/noac126","article-title":"Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: a contemporary single-institution experience","volume":"24","author":"Saraf","year":"2022","journal-title":"Neuro Oncol"},{"issue":"15","key":"10.1016\/j.neurot.2026.e01061_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153708","article-title":"Adult medulloblastoma: updates on current management and future perspectives","volume":"14","author":"Franceschi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib89","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/neuonc\/nox155","article-title":"Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)","volume":"20","author":"Beier","year":"2018","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01061_bib90","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/1078-0432.CCR-13-1710","article-title":"A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor sonidegib (LDE225) in patients with advanced solid tumors","volume":"20","author":"Rodon","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib91","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/neuonc\/noab087","article-title":"MEVITEM-a phase I\/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent\/refractory medulloblastoma with sonic hedgehog pathway activation","volume":"23","author":"Frappaz","year":"2021","journal-title":"Neuro Oncol"},{"issue":"24","key":"10.1016\/j.neurot.2026.e01061_bib92","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1200\/JCO.2014.60.1591","article-title":"Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032","volume":"33","author":"Robinson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib93","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noad137.442","article-title":"P20.16.B first-line treatment of medulloblastoma in adolescents and adults - update on the EORTC 1634-BTG\/NOA-23 phase II trial","volume":"25","author":"Hau","year":"2023","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020414","article-title":"The alliance AMBUSH trial: rationale and design","volume":"14","author":"Mahajan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib95","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-019-03173-4","article-title":"Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015","volume":"143","author":"Gittleman","year":"2019","journal-title":"J Neuro Oncol"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01061_bib96","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S1470-2045(15)00244-2","article-title":"Consensus on the management of intracranial germ-cell tumours","volume":"16","author":"Murray","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib97","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/neuonc\/noab295","article-title":"Outcomes of intracranial germinoma-A retrospective multinational Asian study on effect of clinical presentation and differential treatment strategies","volume":"24","author":"Koh","year":"2022","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01061_bib98","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11912-023-01416-2","article-title":"Intracranial germinomas: diagnosis, pathogenesis, clinical presentation, and management","volume":"25","author":"Kremenevski","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01061_bib99","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/pbc.24097","article-title":"Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma","volume":"59","author":"Allen","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ijrobp.2020.05.019","article-title":"Optimization of intracranial germinoma treatment: radiotherapy alone with reduced volume and dose","volume":"108","author":"Byun","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib101","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/neuonc\/noab252","article-title":"EANO, SNO and euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","volume":"24","author":"Frappaz","year":"2022","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF00240671","article-title":"Monitoring tumour response","volume":"6","author":"Husband","year":"1996","journal-title":"Eur Radiol"},{"key":"10.1016\/j.neurot.2026.e01061_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcped.2024.100146","article-title":"Overview of current European practice for the management of patients with intracranial germ cell tumours","volume":"3","author":"Diezi","year":"2024","journal-title":"EJC Paediatric Oncology"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31628","article-title":"Treatment approach for metastatic intracranial germinoma: a multi-institutional experience","volume":"72","author":"Power","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.neurot.2026.e01061_bib105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.acr.2025.08.005","article-title":"Non-germinomatous germ cell tumors of the CNS: classification, diagnosis, and treatment","volume":"167","author":"Takami","year":"2025","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01061_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104615","article-title":"Optimal treatment strategy for central nervous system non-germinomatous germ cell tumors: a systematic review and meta-analysis","volume":"207","author":"Zhou","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib107","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1078-0432.CCR-23-4033","article-title":"Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors","volume":"30","author":"Hansford","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib108","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1470-2045(24)00640-5","article-title":"The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study","volume":"26","author":"Negm","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11060-025-05261-0","article-title":"Unveiling MMR deficiency in pediatric and AYA high-grade gliomas: insights from multiomic profiling","volume":"176","author":"Bhardwaj","year":"2025","journal-title":"J Neuro Oncol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1470-2045(24)00026-3","article-title":"Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an international replication repair deficiency consortium cohort study","volume":"25","author":"Ercan","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib111","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41698-024-00597-8","article-title":"Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome","volume":"8","author":"Palova","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib112","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/PO.21.00153","article-title":"Upfront adjuvant immunotherapy of replication repair-deficient pediatric glioblastoma with chemoradiation-sparing approach","volume":"5","author":"Larkin","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib113","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/nop\/npv051","article-title":"Genetic counseling and tumor predisposition in neuro-oncology practice","volume":"3","author":"Dunbar","year":"2016","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.neurot.2026.e01061_bib114","article-title":"Mismatch repair deficiency and Lynch syndrome among adult patients with glioma","volume":"7","author":"Benusiglio","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international Tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib116","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1212\/WNL.0000000000009458","article-title":"Nonoptic pathway tumors in children with neurofibromatosis type 1","volume":"95","author":"Mahdi","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib117","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"Rasmussen","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib118","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01061_bib119","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaneurol.2017.1406","article-title":"Association of genetic predisposition with solitary schwannoma or meningioma in children and young adults","volume":"74","author":"Pathmanaban","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/WNL.0000000000003418","article-title":"Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis","volume":"88","author":"Smith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e01061_bib121","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/2152-7806.85609","article-title":"Malignant psammomatous melanotic schwannoma of the spine: a component of carney complex","volume":"2","author":"Shields","year":"2011","journal-title":"Surg Neurol Int"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib122","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00401-021-02304-4","article-title":"Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype","volume":"141","author":"Kresbach","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib123","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.14461","article-title":"Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition","volume":"176","author":"Valdez","year":"2017","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib124","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/bjd.14485","article-title":"CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature","volume":"175","author":"Sargen","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/NP301022","article-title":"Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A\/B deletion and a significant family history","volume":"36","author":"Chan","year":"2017","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.neurot.2026.e01061_bib126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/CMAR.S362678","article-title":"Neurofibromatosis type 1-Associated optic pathway gliomas: current challenges and future prospects","volume":"15","author":"Tang","year":"2023","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010114","article-title":"An update on neurofibromatosis type 1-Associated gliomas","volume":"12","author":"Lobbous","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib128","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/pbc.25149","article-title":"Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population","volume":"61","author":"Bates","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.neurot.2026.e01061_bib129","unstructured":"Evans D. NF2-Related schwannomatosis. Seattle (WA): University of Washington, Seattle: In: Adam MP, Bick S, Mirzaa GM, et al., editors. (GeneReviews\u00ae [Internet])."},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13053-022-00230-4","article-title":"Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore","volume":"20","author":"Loh","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11061005","article-title":"Synchronous Presentation of Rare Brain Tumors in Von Hippel-Lindau Syndrome","volume":"11","author":"Lodi","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.neurot.2026.e01061_bib132","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fneur.2019.00705","article-title":"Clinical characteristics of subependymal giant cell astrocytoma in Tuberous sclerosis complex","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018015","article-title":"Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil","volume":"6","author":"Custodio","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3340\/jkns.2018.0031","article-title":"Pediatric high grade gliomas in the context of cancer predisposition syndromes","volume":"61","author":"Michaeli","year":"2018","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/neuonc\/noz154","article-title":"Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas","volume":"22","author":"Surun","year":"2020","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib136","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10689-019-00126-8","article-title":"Pediatric craniopharyngioma in association with familial adenomatous polyposis","volume":"18","author":"Dahl","year":"2019","journal-title":"Fam Cancer"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib137","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/neuonc\/noae111","article-title":"Medulloblastoma in children with Fanconi anemia: association with FA-D1\/FA-N, SHH type and poor survival independent of treatment strategies","volume":"26","author":"S\u00f6nksen","year":"2024","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bjc.1997.354","article-title":"The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma","volume":"76","author":"Cowan","year":"1997","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01061_bib139","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1158\/1078-0432.CCR-08-2023","article-title":"Medulloblastoma variants: age-dependent occurrence and relation to gorlin syndrome--a new clinical perspective","volume":"15","author":"Garr\u00e8","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01061_bib140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.25259\/SNI_555_2023","article-title":"Lhermitte-duclos disease: a systematic review","volume":"14","author":"Alanazi","year":"2023","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.neurot.2026.e01061_bib141","series-title":"Rhabdoid tumor predisposition syndrome [text]","author":"Nemes","year":"2022"},{"key":"10.1016\/j.neurot.2026.e01061_bib142","article-title":"Melanotic schwannomas are rarely seen pigmented tumors with unpredictable prognosis and challenging diagnosis","volume":"2017","author":"Keskin","year":"2017","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.neurot.2026.e01061_bib143","series-title":"DICER1-Related tumor predisposition [text]","author":"Schultz","year":"2014"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib144","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3174\/ajnr.A8039","article-title":"Newly recognized genetic tumor syndromes of the CNS in the 5th WHO classification: imaging overview with genetic updates","volume":"45","author":"Agarwal","year":"2024","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1897-4287-4-4-169","article-title":"Familial paragangliomas","volume":"4","author":"Lips","year":"2006","journal-title":"Hered Cancer Clin Pract"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib146","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4103\/IJO.IJO_2414_23","article-title":"Retinoblastoma - a comprehensive review, update and recent advances","volume":"72","author":"Nag","year":"2024","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib147","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djae250","article-title":"Prevalence of cancer survivors diagnosed during adolescence and young adulthood in the United States","volume":"117","author":"Page","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib148","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib149","first-page":"381","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01061_bib150","first-page":"95","article-title":"Adverse health outcomes and health-related quality of life (HRQoL) among long-term adolescent and young adult (AYA) brain tumour survivors: results from the population-based SURVAYA study","volume":"33","author":"Angoumis","year":"2025","journal-title":"Support Care Cancer"},{"issue":"Supplement_3","key":"10.1016\/j.neurot.2026.e01061_bib151","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noae047","article-title":"CBTRUS statistical report: american brain tumor association & NCI neuro-oncology branch adolescent and young adult primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01061_bib152","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01061_bib153","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(09)70317-1","article-title":"Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood","volume":"11","author":"Knopman","year":"2010","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.neurot.2026.e01061_bib154","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review","volume":"36","author":"van Dorp","year":"2018","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.neurot.2026.e01061_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70486","article-title":"Fertility preservation access among female adolescents and young adults with cancer: a systematic review","volume":"132","author":"Algave","year":"2026","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib156","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ijc.33218","article-title":"Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: a population-based cohort study","volume":"148","author":"Reulen","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01061_bib157","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijrobp.2013.03.034","article-title":"Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the childhood cancer survivor study","volume":"86","author":"Mueller","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01061_bib158","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/S1470-2045(25)00410-3","article-title":"Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU-CAYAS-NET consortium","volume":"26","author":"Wams","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib159","doi-asserted-by":"crossref","DOI":"10.1007\/s11764-024-01597-0","article-title":"Health-related quality of life of long-term adolescent and young adult (AYA) cancer survivors compared to a matched normative population: results of the SURVAYA study","author":"Janssen","year":"2025","journal-title":"J Cancer Surviv"},{"issue":"27","key":"10.1016\/j.neurot.2026.e01061_bib160","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1200\/JCO.2018.78.0627","article-title":"Cognition in adolescent and young adults diagnosed with cancer: an understudied problem","volume":"36","author":"Jim","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib161","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1215\/S1152851702000431","article-title":"The neurocognitive effects of radiation in adult low-grade glioma patients","volume":"5","author":"Brown","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurot.2026.e01061_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111574","article-title":"Neurocognition after brain irradiation: dose-volume effects and regional radiosensitivity - a systematic review by the ESTRO CNS focus group","volume":"221","author":"Turcas","year":"2026","journal-title":"Radiother Oncol"},{"issue":"17","key":"10.1016\/j.neurot.2026.e01061_bib163","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/cncr.31593","article-title":"Social adjustment in adolescent survivors of pediatric central nervous system tumors: a report from the childhood cancer survivor study","volume":"124","author":"Schulte","year":"2018","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.neurot.2026.e01061_bib164","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1200\/JCO.23.01615","article-title":"Mental disorders among adolescents and young adults with cancer: a Canadian population-based and sibling cohort study","volume":"42","author":"Oberoi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10334","key":"10.1016\/j.neurot.2026.e01061_bib165","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(22)00460-3","article-title":"Long-term care for people treated for cancer during childhood and adolescence","volume":"399","author":"Tonorezos","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib166","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamapediatrics.2024.0642","article-title":"Burden of childhood cancer and the social and economic challenges in adulthood: a systematic review and meta-analysis","volume":"178","author":"Hern\u00e1dfoi","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01061_bib167","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11764-019-00808-3","article-title":"Social attainment in survivors of pediatric central nervous system tumors: a systematic review and meta-analysis from the children's oncology group","volume":"13","author":"Schulte","year":"2019","journal-title":"J Cancer Surviv"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01061_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31327","article-title":"A systematic review of interventions for neurocognitive dysfunctions in patients and survivors of a pediatric brain tumor","volume":"71","author":"Bullens","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib169","first-page":"CD007569","article-title":"Non-medical interventions to enhance return to work for people with cancer","volume":"3","author":"de Boer","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01061_bib170","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ccell.2021.09.012","article-title":"Serial assessment of measurable residual disease in medulloblastoma liquid biopsies","volume":"39","author":"Liu","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib171","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-024-02842-7","article-title":"Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method","volume":"149","author":"Madlener","year":"2025","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01061_bib172","doi-asserted-by":"crossref","DOI":"10.1002\/1545-5017.70093","article-title":"Cerebrospinal fluid liquid biopsy enables targeted therapy without tissue diagnosis in pediatric low-grade gliomas with BRAF V600E mutation","volume":"73","author":"Sultan","year":"2026","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01061_bib173","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s40478-024-01886-w","article-title":"High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumors","volume":"12","author":"Nakano","year":"2024","journal-title":"Acta Neuropathol Commun"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792600231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792600231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:54:58Z","timestamp":1792720498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792600231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":173,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S187874792600231X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01061","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01061"}}